# Safety and Tolerability of Retinoid QLT091001 in Healthy Volunteers

> **NCT00765427** · PHASE1 · COMPLETED · sponsor: **QLT Inc.** · enrollment: 18 (estimated)

## Conditions studied

- Healthy Human Volunteers

## Interventions

- **DRUG:** QLT091001

## Key facts

- **NCT ID:** NCT00765427
- **Lead sponsor:** QLT Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2009-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00765427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00765427, "Safety and Tolerability of Retinoid QLT091001 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00765427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*